Rosiglitazone counteracts palmitate-induced β-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities

Author: Abaraviciene S.   Lundquist I.   Salehi A.  

Publisher: Springer Publishing Company

ISSN: 1420-682X

Source: Cellular and Molecular Life Sciences CMLS, Vol.65, Iss.14, 2008-07, pp. : 2256-2265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content